J. Arana

发表

2463. Post-licensure Surveillance of 9-Valent Human Papillomavirus Vaccine (9vHPV) in the Vaccine Adverse Event Reporting System (VAERS), United States, 2014–2017

T. Shimabukuro, L. Markowitz, J. Arana, 2018, Open Forum Infectious Diseases.

Adverse events following administration to pregnant women of influenza A (H1N1) 2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting System.

Kimp Walton, F. Destefano, D. Kissin, 2011, American journal of obstetrics and gynecology.

Safety of Influenza A (H1N1) 2009 Live Attenuated Monovalent Vaccine in Pregnant Women

D. Kissin, J. Cragan, Y. Zheteyeva, 2013, Obstetrics and gynecology.

Reports of Postural Orthostatic Tachycardia Syndrome After Human Papillomavirus Vaccination in the Vaccine Adverse Event Reporting System.

T. Shimabukuro, J. Arana, Paige W. Lewis, 2017, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

Deaths Reported to the Vaccine Adverse Event Reporting System, United States, 1997-2013.

T. Shimabukuro, J. Arana, Paige W. Lewis, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Safety of the 9-Valent Human Papillomavirus Vaccine

T. Shimabukuro, J. Arana, John R Su, 2019, Pediatrics.

Post-licensure safety monitoring of quadrivalent human papillomavirus vaccine in the Vaccine Adverse Event Reporting System (VAERS), 2009-2015.

T. Shimabukuro, L. Markowitz, T. Harrington, 2018, Vaccine.

Comparison of Post-Licensure Safety Surveillance of 13-Valent Pneumococcal Conjugate Vaccine and 7-Valent Pneumococcal Conjugate Vaccine: Data from the Vaccine Advere Event Reporting System (Vaers)

J. Arana, Jorge E Arana, 2011 .

A cluster of nonspecific adverse events in a military reserve unit following pandemic influenza A (H1N1) 2009 vaccination-possible stimulated reporting?

J. Tokars, Mark J. Lamias, M. McNeil, 2012, Vaccine.

Adverse Events following Administration to Pregnant Women of Influenza A (H1N1) 2009 Monovalent Vaccine reported to the Vaccine Adverse Event Reporting System (VAERS).

Kimp Walton, F. Destefano, D. Kissin, 2019 .

Clinical presentation and outcome of patients diagnosed with active tuberculosis in a critical care unit

J. Arana, H. L. Ramos, 2020 .

Post-licensure surveillance of 13-valent pneumococcal conjugate vaccine (PCV13) in adults aged ⩾19years old in the United States, Vaccine Adverse Event Reporting System (VAERS), June 1, 2012-December 31, 2015.

P. Haber, T. Pilishvili, J. Arana, 2016, Vaccine.

Is there any harm in administering extra-doses of vaccine to a person? Excess doses of vaccine reported to the Vaccine Adverse Event Reporting System (VAERS), 2007-2017.

J. Arana, M. Cano, B. Hibbs, 2019, Vaccine.

Postlicensure safety surveillance for high-dose trivalent inactivated influenza vaccine in the Vaccine Adverse Event Reporting System, 1 July 2010-31 December 2010.

David Martin, D. Menschik, P. Haber, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.